BDSX FY 2022 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

FY 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$38M-29.9% YoY

Gross Profit

$24M63.0% margin

Operating Income

-$51M-132.4% margin

Net Income

-$65M-171.3% margin

EPS (Diluted)

$-31.00

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$49M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$93M

Total Liabilities

$72M

Stockholders' Equity

$21M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$55M	-29.9%
Gross Profit	$24M	$24M	+0.3%
Operating Income	-$51M	-$41M	-23.6%
Net Income	-$65M	-$43M	-51.6%